121 related articles for article (PubMed ID: 1788827)
1. The effect of thrombin inhibition in a rat arterial thrombosis model.
Broersma RJ; Kutcher LW; Heminger EF
Thromb Res; 1991 Nov; 64(4):405-12. PubMed ID: 1788827
[TBL] [Abstract][Full Text] [Related]
2. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
Hanson SR; Harker LA
Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
[TBL] [Abstract][Full Text] [Related]
3. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
[TBL] [Abstract][Full Text] [Related]
4. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin.
Kelly AB; Hanson SR; Henderson LW; Harker LA
J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754
[TBL] [Abstract][Full Text] [Related]
5. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons.
Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA
Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462
[TBL] [Abstract][Full Text] [Related]
6. Agglutination of rabbit platelets in plasma by the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
Packham MA; Bryant NL; Guccione MA
Thromb Haemost; 1990 Apr; 63(2):282-5. PubMed ID: 2363129
[TBL] [Abstract][Full Text] [Related]
7. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood.
Wagner WR; Hubbell JA
J Lab Clin Med; 1990 Nov; 116(5):636-50. PubMed ID: 2104522
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin inhibits the thrombotic response to arterial injury in mice.
Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
10. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
Liu JT; Paul W; Emerson M; Cicala C; Page CP
Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
[TBL] [Abstract][Full Text] [Related]
11. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
12. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.
Hollenbach S; Sinha U; Lin PH; Needham K; Frey L; Hancock T; Wong A; Wolf D
Thromb Haemost; 1994 Mar; 71(3):357-62. PubMed ID: 8029801
[TBL] [Abstract][Full Text] [Related]
14. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Elg M; Gustafsson D; Deinum J
Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary fibrin microembolism with Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
Schaeffer RC; Chilton SM; Hadden TJ; Carlson RW
J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec; 57(6):1824-8. PubMed ID: 6511556
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the rat.
De Clerck F; Van Gorp L; Beetens J; Verheyen A; Janssen PA
Blood Coagul Fibrinolysis; 1990 Aug; 1(3):247-58. PubMed ID: 2151728
[TBL] [Abstract][Full Text] [Related]
17. Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit.
Bevilacqua C; Finesso M; Prosdocimi M
Thromb Res; 1991 May; 62(4):263-73. PubMed ID: 1866710
[TBL] [Abstract][Full Text] [Related]
18. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis.
Schumacher WA; Balasubramanian N; St Laurent DR; Seiler SM
Eur J Pharmacol; 1994 Jul; 259(2):165-71. PubMed ID: 7957610
[TBL] [Abstract][Full Text] [Related]
20. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
